β PCP and its analogues are potent dissociatives with significant risk of psychosis, violent behavior, and overdose. Effects are highly unpredictable and dose-sensitive.
π§ͺThis is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.
3-MeO-PCP is a dissociative anesthetic with effects that are compared to PCP and ketamine. It is an NMDA receptor antagonist. It has been available in online research chemical markets since 2010, with wide distribution beginning in 2011.
Perspectives
“Iβm not sure if itβs easy to hole on 3-MeO-PCP by itself. It seems like you need some sort of potentiator. A lot of weed seemed to really do the trick though.”
Build-updevelops with repeated use over days to weeks
Reset2β4 weeks for noticeable reduction
Tolerance Decay
Full tolerance
3dHalf tolerance
7dBaseline
~14d
Model reflects rapid tolerance build with frequent use and slow decay over weeks as commonly reported for arylcyclohexylamines; confidence is limited due to reliance on user reports rather than controlled studies.